Terumo's OPUSWAVE® Imaging System Makes Debut in U.S. Healthcare, Enhancing Coronary Interventions

Introduction to Terumo's OPUSWAVE® Imaging System

On June 15, 2026, a landmark event occurred in the field of interventional cardiology, when Terumo Interventional Systems (TIS) completed the very first procedure utilizing its OPUSWAVE® Dual Sensor Imaging System at the Mount Sinai Fuster Heart Hospital in New York. This advanced technology addresses significant challenges in coronary interventions, markedly enhancing the capabilities available to cardiologists nationwide.

The Technology Behind OPUSWAVE®

The OPUSWAVE Imaging System integrates two powerful imaging modalities—Optical Frequency Domain Imaging (OFDI) and intravascular ultrasound (IVUS)—into a single device, known as the DualView® Imaging Catheter. This innovation not only provides simultaneous views of coronary anatomy but also facilitates informed treatment strategies across a range of procedures, effectively merging the advantages of both deep visualization and high-resolution detail in one platform.

The challenge faced by clinicians has consistently been the need to choose between the depth provided by IVUS and the detailed surface anatomy offered by OFDI. With the introduction of the OPUSWAVE®, this tradeoff is eliminated.

Clinical Impact

According to Dr. Annapoorna S. Kini, the lead physician in the first U.S. procedure, the ability to view both IVUS and OFDI outputs concurrently transforms how interventional cardiologists approach complex coronary cases. “Instead of having to choose, we can now see both depth and resolution, allowing for a more nuanced understanding of the vessels we are working with,” noted Dr. Kini. This capability significantly boosts physicians' confidence in their clinical decisions, which is crucial in such high-stakes environments.

Gray Fleming, Senior Vice President of Sales and Marketing for TIS-US, elaborated further on the advantages, stating, “The OPUSWAVE Imaging System enables physicians to visualize in a manner that reveals the full picture—from vessel structure to surface details. This dual view offers a clearer understanding and leads to more decisive actions.”

Revolutionary Benefits for Physicians

The recent advancements in the OPUSWAVE system reflect feedback obtained from recent market research conducted with medical professionals. Clarity in imaging leads not only to better procedural choices but also fosters heightened diagnostic confidence in navigating complex coronary diseases. Historically, cardiologists had to weigh the benefits of two differing imaging approaches; the OPUSWAVE system superbly resolves this dilemma.

Dr. Michael J. Martinelli, Chief Medical Officer for Terumo Medical Corporation, stressed that the OPUSWAVE is a game-changer in real-time decision-making, as it grants physicians enhanced clarity and insight based on the information garnered from both imaging techniques. This leads to more informed interventions tailored to individual patient needs.

Engineering Excellence

The DualView Imaging Catheter is meticulously designed for optimal performance and ease of use, incorporating a 2.6 Fr profile and exhibiting compatibility with 6 Fr guides. Its advanced hydrophilic coating facilitates seamless navigation through the vascular system, while a substantial 150 mm pullback capability ensures comprehensive diagnostic coverage in a single effort. Flexibility is further optimized through three distinct imaging modes: IVUS-only, OFDI-only, and simultaneous dual imaging. This versatility allows physicians the freedom to tailor their imaging technique according to the specific clinical scenario presented.

About Terumo Interventional Systems

Terumo Interventional Systems is recognized as a leader in minimally invasive entry site management and therapeutic interventions. Their extensive range of innovative products are notably employed in advanced coronary and endovascular treatments. TIS's strategic focuses entail improvements in Transradial Access, Complex Coronary Interventions, and Peripheral Artery Disease, among others. Terumo, founded in Tokyo in 1921, remains committed to enhancing healthcare worldwide by providing comprehensive solutions across numerous medical domains.

For more information on Terumo and its groundbreaking innovations, visit Terumo's official site.